"Adoptive Transfer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE).
| Descriptor ID |
D019264
|
| MeSH Number(s) |
E02.095.465.425.400.330.050 E05.478.550.520.050
|
| Concept/Terms |
Adoptive Cell Transfer- Adoptive Cell Transfer
- Adoptive Cell Transfers
- Cell Transfer, Adoptive
- Cell Transfers, Adoptive
|
Below are MeSH descriptors whose meaning is more general than "Adoptive Transfer".
Below are MeSH descriptors whose meaning is more specific than "Adoptive Transfer".
This graph shows the total number of publications written about "Adoptive Transfer" by people in this website by year, and whether "Adoptive Transfer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 4 | 6 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 5 | 5 |
| 2001 | 1 | 3 | 4 |
| 2002 | 1 | 3 | 4 |
| 2003 | 4 | 2 | 6 |
| 2004 | 3 | 4 | 7 |
| 2005 | 4 | 6 | 10 |
| 2006 | 6 | 10 | 16 |
| 2007 | 1 | 11 | 12 |
| 2008 | 3 | 5 | 8 |
| 2009 | 2 | 10 | 12 |
| 2010 | 2 | 10 | 12 |
| 2011 | 4 | 8 | 12 |
| 2012 | 4 | 7 | 11 |
| 2013 | 6 | 15 | 21 |
| 2014 | 3 | 18 | 21 |
| 2015 | 4 | 6 | 10 |
| 2016 | 5 | 4 | 9 |
| 2017 | 0 | 6 | 6 |
| 2018 | 3 | 3 | 6 |
| 2019 | 5 | 4 | 9 |
| 2020 | 3 | 2 | 5 |
| 2021 | 2 | 2 | 4 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adoptive Transfer" by people in Profiles.
-
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma. Blood. 2022 03 03; 139(9):1289-1301.
-
Protection of Quiescence and Longevity of IgG Memory B Cells by Mitochondrial Autophagy. J Immunol. 2022 03 01; 208(5):1085-1098.
-
Interleukin-10 Producing T Lymphocytes Attenuate Dermal Scarring. Ann Surg. 2021 10 01; 274(4):627-636.
-
Clonally Focused Public and Private T Cells in Resected Brain Tissue From Surgeries to Treat Children With Intractable Seizures. Front Immunol. 2021; 12:664344.
-
Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications. Front Immunol. 2020; 11:611638.
-
Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production. Sci Transl Med. 2021 02 03; 13(579).
-
Chimeric antigen receptor natural killer cells for the treatment of patients with B-cell malignancies. Clin Adv Hematol Oncol. 2020 09; 18(9):543-545.
-
Calcineurin Inhibitor Voclosporin Preserves Corneal Barrier and Conjunctival Goblet Cells in Experimental Dry Eye. J Ocul Pharmacol Ther. 2020 11; 36(9):679-685.
-
Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules. Clin Exp Immunol. 2020 08; 201(2):205-221.
-
Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction. JCI Insight. 2020 03 26; 5(6).